Transcriptomic characterization of human pancreatic CD206- and CD206 + macrophages
Alexander Jonsson1, Olle Korsgren2,3, Anders Hedin2
1Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. alexander.jonsson@igp.uu.se.
Scientific Reports
|April 8, 2025
Summary
This study reveals distinct gene expression profiles for CD206-negative and CD206-positive macrophages in the human pancreas. These macrophage subsets exhibit unique roles in immune regulation and tissue homeostasis.
Area of Science:
- Immunology
- Molecular Biology
- Endocrinology
Background:
- Macrophages are crucial for organ homeostasis and immune regulation.
- Pancreatic macrophage gene expression remains largely uncharacterized.
- Understanding these cells is vital for pancreatic health and disease.
Purpose of the Study:
- To characterize global gene expression in human pancreatic macrophage subpopulations.
- To identify differences between CD206-negative and CD206-positive macrophages.
- To explore macrophage gene expression in pancreatic islets versus exocrine tissue.
Main Methods:
- Human pancreatic tissue (islets and exocrine) was collected.
- Macrophages were isolated and sorted into CD206-negative and CD206-positive populations using flow cytometry.
- RNA sequencing (RNA-seq) was performed for gene expression analysis.
Main Results:
- CD206-negative macrophages showed enrichment in cell cycle regulation, glycolysis, and immunosuppression (SPP1).
- CD206-positive macrophages were enriched in immune regulation (complement, coagulation, IL-10, IL-2RA) and scavenging pathways.
- Distinct gene expression patterns were observed between islet and exocrine macrophages, particularly for the CD206-negative subset.
Conclusions:
- Human pancreatic CD206-negative and CD206-positive macrophages possess distinct functional gene expression profiles.
- These macrophage subsets play specialized roles in pancreatic immune regulation and tissue-specific functions.
- Further research into these distinct macrophage populations may reveal therapeutic targets for pancreatic diseases.


